Cited In for PMID: 27646948

Year	Number of Results
2016	2
2017	4
2018	4
2019	1
2020	5
2021	13
2022	7
2023	14
2024	4
2025	3
2026	2

1

Statins Are Associated With Reduced Mortality in Multiple Myeloma.

Sanfilippo KM, Keller J, Gage BF, Luo S, Wang TF, Moskowitz G, Gumbel J, Blue B, O'Brian K, Carson KR. Sanfilippo KM, et al. J Clin Oncol. 2016 Nov 20;34(33):4008-4014. doi: 10.1200/JCO.2016.68.3482. Epub 2016 Sep 30. J Clin Oncol. 2016. PMID: 27646948 Free PMC article.

2

Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials.

Abuhelwa AY, Almansour SA, Al-Shamsi HO, Abuhelwa Z, Alqudah MAY, Bustanji Y, Semreen MH, Alzoubi KH, Modi ND, McKinnon RA, Sorich MJ, Hopkins AM. Abuhelwa AY, et al. Sci Rep. 2026 Feb 7;16(1):7683. doi: 10.1038/s41598-026-37464-4. Sci Rep. 2026. PMID: 41651961 Free PMC article. Clinical Trial.

3

Rosuvastatin in Combination With Bortezomib Promotes Osteogenesis in Myeloma Bone Disease by Inhibiting the Secretion of CCL3.

Qu F, Hui M, Yang F, Huang B, Liu N, He Y, Wang X. Qu F, et al. EJHaem. 2026 Jan 28;7(1):e70232. doi: 10.1002/jha2.70232. eCollection 2026 Feb. EJHaem. 2026. PMID: 41613950 Free PMC article.

4

LRP8-dependent cholesterol metabolism modulates mTORC1 signaling and apoptotic pathways in multiple myeloma.

Wang Y, Lan T, Zhou C, Zhang Q, Liu P. Wang Y, et al. Cell Death Dis. 2025 Apr 8;16(1):263. doi: 10.1038/s41419-025-07625-w. Cell Death Dis. 2025. PMID: 40199866 Free PMC article.

5

Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions.

Wang H, Zhang J, Ren H, Chen L, Ren J, Liu C, Wu H, Zhou L. Wang H, et al. Front Oncol. 2025 Mar 5;15:1531928. doi: 10.3389/fonc.2025.1531928. eCollection 2025. Front Oncol. 2025. PMID: 40110197 Free PMC article. Review.

6

Targeting Caveolin-1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell-Mediated Immunotherapy.

Zhan D, Du Z, Zhang S, Huang J, Zhang J, Zhang H, Liu Z, Menu E, Wang J. Zhan D, et al. Adv Sci (Weinh). 2025 Jan;12(4):e2408373. doi: 10.1002/advs.202408373. Epub 2024 Dec 4. Adv Sci (Weinh). 2025. PMID: 39630017 Free PMC article.

7

Different Strategies to Overcome Resistance to Proteasome Inhibitors-A Summary 20 Years after Their Introduction.

Tyrna P, Procyk G, Szeleszczuk Ł, Młynarczuk-Biały I. Tyrna P, et al. Int J Mol Sci. 2024 Aug 16;25(16):8949. doi: 10.3390/ijms25168949. Int J Mol Sci. 2024. PMID: 39201634 Free PMC article. Review.

8

Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients.

Al-Odat OS, Nelson E, Budak-Alpdogan T, Jonnalagadda SC, Desai D, Pandey MK. Al-Odat OS, et al. Cancers (Basel). 2024 Jun 28;16(13):2381. doi: 10.3390/cancers16132381. Cancers (Basel). 2024. PMID: 39001443 Free PMC article. Review.

9

Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma.

Allegra A, Murdaca G, Mirabile G, Gangemi S. Allegra A, et al. Biomedicines. 2024 Feb 24;12(3):514. doi: 10.3390/biomedicines12030514. Biomedicines. 2024. PMID: 38540127 Free PMC article. Review.

10

Risk profiles and incidence of cardiovascular events across different cancer types.

Mitchell JD, Laurie M, Xia Q, Dreyfus B, Jain N, Jain A, Lane D, Lenihan DJ. Mitchell JD, et al. ESMO Open. 2023 Dec;8(6):101830. doi: 10.1016/j.esmoop.2023.101830. Epub 2023 Nov 17. ESMO Open. 2023. PMID: 37979325 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 27646948

55 results

Results by year